PEOPLE ON THE MOVE
Lifeprint
GenePeeks, a subsidiary of Lifeprint Group, has announced Mara Aspinall will join its board as Executive Chairman.
GenePeeks is a gene testing company focused on disease risk analysis. It digitally combines prospective parents’ DNA to predict the couple’s “virtual progeny” and evaluate their future children’s risk for recessive genetic diseases.
Aspinall is the former President and CEO of Ventana Medical Systems, a cancer diagnostics firm that is a member of the Roche Group. She currently serves as the CEO of consultancy Health Catalysts.